Archeus hopes to begin a Phase I trial of the PSMA-targeted agent in metastatic, castration-resistant prostate cancer later this year.

Mogensen AW et al. The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer ...

Surgery and radiation yield similar cancer outcomes for low-risk prostate cancer, but higher-risk cases may require combining ...

Experts from CO Architects, SOM, UW Health, City of Hope, and E4H discuss design trends shaping cancer care facility projects ...

Aetna Life Insurance Co. agreed to pay more than $3.4 million to settle a proposed class action by prostate cancer patients ...

Read full article: Proactive screening matters: How men can take charge of their prostate health No prostate cancer ... “Proton Therapy works by delivering a very focused proton beam of energy ...

Proton beam therapy does not improve the patient-reported outcome of bowel function compared with IMRT. Bowel side effects do not differ between patients with localized prostate cancer who receive ...

and proton beam therapy (PBT) offer similar outcomes for patients with localized prostate cancer, according to a study presented at the annual meeting of the American Society for Radiation ...

For patients with intermediate- or low-risk localized prostate cancer, intensity-modulated radiation therapy (IMRT) and proton beam therapy are both safe and effective options, according to ...

Many men with prostate cancer undergo external beam radiation ... advanced forms of external beam radiation — IMRT and proton beam therapy — head to head.” Efstathiou and colleagues randomly ...

A large trial of people with earlier stages of prostate cancer compared two types of external radiation treatments head-to-head—proton beam therapy and intensity-modulated radiation therapy ...

WASHINGTON, September 30, 2024 — People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy — proton beam therapy or intensity ...